Related references
Note: Only part of the references are listed.Cancer Stem Cells in the Central Nervous System - A Critical Review
Lars Prestegarden et al.
CANCER RESEARCH (2010)
Glioma Cell Populations Grouped by Different Cell Type Markers Drive Brain Tumor Growth
Lars Prestegarden et al.
CANCER RESEARCH (2010)
ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction
Sen-Tien Tsai et al.
EUROPEAN JOURNAL OF CANCER (2010)
Expression of diagnostic neuronal markers and outcome in glioblastoma
K. Donev et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2010)
Hypoxia Helps Glioma to Fight Therapy
Verena Amberger-Murphy
CURRENT CANCER DRUG TARGETS (2009)
Tubulin Targets in the Pathobiology and Therapy of Glioblastoma Multiforme. I. Class III β-Tubulin
Christos D. Katsetos et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Glycolytic enzyme inhibitors in cancer treatment
Roberto Scatena et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Ependymomas with neuronal differentiation: a morphologic and immunohistochemical spectrum
Fausto J. Rodriguez et al.
ACTA NEUROPATHOLOGICA (2007)
Angiogenesis-independent tumor growth mediated by stem-like cancer cells
Per O. Sakariassen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
New variants of malignant glioneuronal tumors: A clinicopathological study of 40 cases
P Varlet et al.
NEUROSURGERY (2004)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer
N Makretsov et al.
HUMAN PATHOLOGY (2003)
Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications
A Perry et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Immunophenotype of pleomorphic xanthoastrocytoma
C Giannini et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Microtubule-associated protein 2 (MAP-2) is expressed in low and high grade diffuse astrocytomas
SB Wharton et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2002)